{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:57Z","timestamp":1786119717716,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"DOI":"10.1097\/qai.0b013e3182182e2d","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T02:45:34Z","timestamp":1300502734000},"page":"305-310","source":"Crossref","is-referenced-by-count":9,"title":["Tuberculosis Risk Before and After Highly Active Antiretroviral Therapy Initiation: Does HAART Increase the Short-Term TB Risk in a Low Incidence TB Setting?"],"prefix":"10.1097","volume":"57","author":[{"given":"April C","family":"Pettit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy A","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E","family":"Stinnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F","family":"Rebeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P","family":"Raffanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210131","first-page":"770","article-title":"Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.","volume":"4","author":"Crowe","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-10-20210131","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","article-title":"A prospective study of the risk of tuberculosis among HIV-infected patients.","volume":"7","author":"Guelar","year":"1993","journal-title":"AIDS"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archinte.1995.00430140115012","article-title":"Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.","volume":"155","author":"Hanson","year":"1995","journal-title":"Arch Intern Med"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.1995.03530020061033","article-title":"Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).","volume":"274","author":"Antonucci","year":"1995","journal-title":"JAMA"},{"key":"R7-10-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R8-10-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R9-10-20210131","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group.","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-10-20210131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R11-10-20210131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R12-10-20210131","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":"Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.","volume":"20","author":"Bonnet","year":"2006","journal-title":"AIDS"},{"key":"R13-10-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R14-10-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R16-10-20210131","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R17-10-20210131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000176221.33237.67","article-title":"Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?","volume":"19","author":"Breen","year":"2005","journal-title":"AIDS"},{"key":"R18-10-20210131","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and unmasking of tuberculosis during antiretroviral therapy.","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-10-20210131","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R21-10-20210131","first-page":"355","article-title":"Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.","volume":"13","author":"Pettit","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"R22-10-20210131","first-page":"209","article-title":"Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States.","volume":"10","author":"Lee","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R23-10-20210131","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/ije\/dyp208","article-title":"Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.","volume":"38","author":"Edmonds","year":"2009","journal-title":"Int J Epidemiol"},{"key":"R24-10-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archinternmed.2007.10","article-title":"Effectiveness of antiretroviral treatment in a South African program: a cohort study.","volume":"168","author":"Fairall","year":"2008","journal-title":"Arch Intern Med"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R26-10-20210131","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1198\/016214501753168154","article-title":"Marginal structural models to estimate the joint causal effect of nonrandomized treatments.","volume":"96","author":"Hernan","year":"2001","journal-title":"J Am Stat Assoc"},{"key":"R27-10-20210131","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"R28-10-20210131","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"R29-10-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.04.00109303","article-title":"Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy.","volume":"24","author":"Girardi","year":"2004","journal-title":"Eur Respir J"},{"key":"R30-10-20210131","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R31-10-20210131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/sti.79.4.337","article-title":"Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy.","volume":"79","author":"Goldsack","year":"2003","journal-title":"Sex Transm Infect"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201108010-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:01:10Z","timestamp":1786042870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201108010-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182182e2d","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,1]]}}}